No phaseStatus unknown

A Study on the Efficacy of Lemborexant in Patients with Insomnia of the Hyperarousal Subtype and Comorbid Cardiovascular Risk

Sponsor
West China Hospital of Sichuan University
Enrolment
55 planned
Conditions
Insomnia
Interventions
Treatment with lemborexant
Ages
adults, older adults
Registry
ChiCTR2600132577

Full record on the Chinese Clinical Trial RegistrySource: WHO ICTRP, processed 21 September 2026

Primary outcomes

  • Change in ISI score from baseline at 3 months;

History

  1. Started

  2. Last registry update

  3. Registered